Search hospitals > Delaware > Newark
Delaware Clinical and Laboratory Physicians PA
Claim this profileNewark, Delaware 19713
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Non-Small Cell Lung Cancer
175 reported clinical trials
2 medical researchers
Summary
Delaware Clinical and Laboratory Physicians PA is a medical facility located in Newark, Delaware. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Delaware Clinical and Laboratory Physicians PA is involved with conducting 175 clinical trials across 343 conditions. There are 2 research doctors associated with this hospital, such as Gregory A. Masters and Mark E. Borowsky.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
Top PIs
Gregory A. MastersHelen F Graham Cancer Center4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
121 reported clinical trials
200 drugs studied
Mark E. BorowskyJersey Shore Medical Center12 years of reported clinical research
Studies Serous Cystadenocarcinoma
Studies Adenocarcinoma
3 reported clinical trials
11 drugs studied
Clinical Trials running at Delaware Clinical and Laboratory Physicians PA
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Diffuse Large B-Cell Lymphoma
Anal Cancer
Oropharyngeal Carcinoma
Lymphoma
Squamous Cell Carcinoma
Anal Squamous Cell Carcinoma
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Whole Brain Radiotherapy + Stereotactic Radiosurgery
for Brain Metastasis
This study is evaluating whether a combination of radiation therapy and memantine may be effective in treating cancer that has come back in the brain. original:
Recruiting2 awards Phase 312 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Delaware Clinical and Laboratory Physicians PA?
Delaware Clinical and Laboratory Physicians PA is a medical facility located in Newark, Delaware. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Delaware Clinical and Laboratory Physicians PA is involved with conducting 175 clinical trials across 343 conditions. There are 2 research doctors associated with this hospital, such as Gregory A. Masters and Mark E. Borowsky.